6.4
6.40 (-2.70%)
As of Mar 06, 2024
Relmada Therapeutics, Inc. [RLMD]
Source:
Company Overview
Relmada Therapeutics, Inc. is a clinical-stage biotechnology company focused on the development of esmethadone, an N-methyl-D-aspartate receptor antagonist. Esmethadone, an isomer of methadone, is a new chemical entity thatpotentially addresses areas of high unmet medical need in the treatment of central nervous system diseases and other disorders.
Country | United States |
Headquarters | coral gables, florida |
Phone Number | 646 876 3459 |
Industry | manufacturing |
CEO | Sergio Traversa |
Website | www.relmada.com |